Both MET and AXL have been implicated in tumor cell survival, antiapoptosis, and tumorigenesis13, 26, 36, 53, 54, 55, 56; however, constitutively activated MET signaling is required for cell survival. The gene discussed is AXL; the disease is neoplasm.